Transsexualism
16
1
1
11
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 16 trials
100.0%
+13.5% vs benchmark
13%
2 trials in Phase 3/4
0%
0 of 11 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 11 completed trials
Clinical Trials (16)
MaPGAS Decision Making
Effects of Cross-sex Hormone Therapy on Eating Behavior, Metabolism, Energy Balance and Cardiovascular System
Effect of Dose Fractionation of Testosterone Cypionate on Transgender Men with Erythrocytosis
HPV Prevalence in Transpersons - a Prospective Study
i2TransHealth: Interdisciplinary, Internet-based Trans Health Care
Use of an External Erectile Device in Transgender Man Following Phalloplasty
GEnder Dysphoria Treatment in Sweden
Transgender Cohort Study of Gender Affirmation and HIV-related Health
Observational Study on Metabolism and Psychopathology in Transsexual Patients
TransCare - Genital Surgery for Trans Women in Centralized vs. Decentralized Health Care Delivery Settings
Sexuality in Transmen During Hormone and Operative Treatment
Testosterone and Its Metabolites in GID
A Common Polymorphism of the SRD5A2 Gene is Not Associated With Male-to-Female and Female-to-Male Transsexualism
First Australian National Trans Mental Health Study
Sex Steroids and the Serotonin Transporter
Decrease of Libido of Post-Operative Male-Female Transsexuals and a Healthy Female Control Group